Evolent Health, Inc (NYSE:EVH) shares dropped 2.7% on Tuesday . The company traded as low as $10.30 and last traded at $11.45. Approximately 1,410,300 shares changed hands during trading, an increase of 16% from the average daily volume of 1,215,002 shares. The stock had previously closed at $11.15.

EVH has been the topic of a number of recent analyst reports. BidaskClub lowered Evolent Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. ValuEngine lowered Evolent Health from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Robert W. Baird set a $35.00 price objective on Evolent Health and gave the stock a “buy” rating in a report on Tuesday, August 8th. Cowen and Company restated an “outperform” rating and set a $33.00 price objective (down from $35.00) on shares of Evolent Health in a report on Wednesday, August 9th. Finally, Zacks Investment Research downgraded Evolent Health from a “hold” rating to a “sell” rating in a report on Thursday, August 10th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have assigned a buy rating to the company. Evolent Health has a consensus rating of “Buy” and a consensus target price of $28.70.

The company has a debt-to-equity ratio of 0.11, a current ratio of 3.34 and a quick ratio of 3.34.

Evolent Health (NYSE:EVH) last released its quarterly earnings results on Thursday, November 2nd. The technology company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. Evolent Health had a negative net margin of 15.86% and a negative return on equity of 5.05%. The business had revenue of $107.90 million for the quarter, compared to the consensus estimate of $104.49 million. During the same quarter last year, the firm earned ($0.26) EPS. Evolent Health’s revenue for the quarter was up 79.2% on a year-over-year basis. research analysts expect that Evolent Health, Inc will post -0.57 EPS for the current year.

A number of large investors have recently added to or reduced their stakes in EVH. Gradient Investments LLC lifted its position in shares of Evolent Health by 3.0% during the second quarter. Gradient Investments LLC now owns 16,719 shares of the technology company’s stock worth $424,000 after purchasing an additional 489 shares in the last quarter. American International Group Inc. lifted its position in shares of Evolent Health by 7.5% during the first quarter. American International Group Inc. now owns 9,403 shares of the technology company’s stock worth $210,000 after purchasing an additional 653 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its position in shares of Evolent Health by 6.0% during the first quarter. Schwab Charles Investment Management Inc. now owns 63,180 shares of the technology company’s stock worth $1,409,000 after purchasing an additional 3,591 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Evolent Health by 3.1% during the first quarter. Geode Capital Management LLC now owns 130,053 shares of the technology company’s stock worth $2,900,000 after purchasing an additional 3,889 shares in the last quarter. Finally, ETF Managers Group LLC acquired a new position in shares of Evolent Health during the second quarter worth approximately $102,000. Hedge funds and other institutional investors own 92.74% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Evolent Health, Inc (EVH) Trading Down 2.7%” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/16/evolent-health-inc-evh-trading-down-2-7.html.

Evolent Health Company Profile

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Receive News & Stock Ratings for Evolent Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc and related stocks with our FREE daily email newsletter.